Breaking News Instant updates and real-time market news.

ESKYF

Eskay Mining

$1.37 /

+0.03 (+2.24%)

08:40
09/01/22
09/01
08:40
09/01/22
08:40

Eskay Mining's maiden Scarlet Valley drilling commences

Eskay Mining Corp. announces maiden drilling at Scarlet Valley, a newly identified volcanogenic massive sulfide center near Scarlet Ridge, part of its 100% controlled Consolidated Eskay project, British Columbia. As of this news release, the Company has completed 22,272 m of diamond core drilling, approximately 74% of the 30,000m planned to be completed in 2022. Drill production is currently on target to reach this aggressive goal with four drills fully operational. Currently two drills are conducting step-out drilling of the Upper Stockwork Zone at TV, and two drills are beginning to define the extent of the intensely mineralized Scarlet Valley target. Preparations are underway to drill the Tarn Lake target immediately following completion of drilling at Scarlet Valley. "Our prospecting and mapping team's work is rapidly identifying and characterizing new VMS targets at Scarlet Ridge and Scarlet Valley, key to quickly advancing these from areas of interest into drilled targets that are now delivering significant sulfide-bearing mineralized intercepts," commented Dr. John DeDecker, Eskay Mining's VP of Exploration. "Mineralization and hydrothermal alteration are extremely intense and widespread throughout areas drilled to date. Much more visible sulfide mineralization awaits us at Scarlet Knob and Tarn Lake. Demonstrating we hold a VMS district by making new discoveries is our goal this season. We are fortunate to have a top-notch team in place to execute a very aggressive, flexible exploration program. So far, we are meeting our objectives set for the 2022 program on schedule." Maiden drilling at Scarlet Valley is underway with drill hole SV22-1 intercepting 95 m of intense sulfide mineralization and hydrothermal alteration. Recent drilling at Scarlet Ridge has intercepted a zone of intense hydrothermal alteration and replacement-style sulfide mineralization. Drilling at Scarlet Ridge and Scarlet Valley as well as recent field investigations at Scarlet Knob-Tarn Lake confirms the presence of replacement-style and stockwork VMS mineralization at all locations. Generally, sulfide mineralization is most intense proximal to east-west trending and vertically oriented basalt dikes suggesting that hydrothermal fluids exploited the same syn-volcanic structures as these dikes during their ascent to the seafloor/sub-seafloor environment.

OTHER BREAKING NEWS FROM THE FLY

Options
Carvana call volume above normal and directionally bullish » 11:45
12/01/22
12/01
11:45
12/01/22
11:45
CVNA

Carvana

$8.01 /

+0.325 (+4.23%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$8.01 /

+0.325 (+4.23%)

CVNA Carvana
$8.01 /

+0.325 (+4.23%)

11/30/22 BofA
BofA downgrades Carvana to Neutral on liquidity concerns
11/30/22 BofA
Carvana downgraded to Neutral from Buy at BofA
11/22/22 Baird
Carvana downgraded to Neutral from Outperform at Baird
11/21/22 Cowen
Carvana downgraded to Market Perform from Outperform at Cowen
CVNA Carvana
$8.01 /

+0.325 (+4.23%)

  • 22
    Apr
CVNA Carvana
$8.01 /

+0.325 (+4.23%)

CVNA Carvana
$8.01 /

+0.325 (+4.23%)

CVNA Carvana
$8.01 /

+0.325 (+4.23%)

General news
8-week bill auction » 11:40
12/01/22
12/01
11:40
12/01/22
11:40
$ECON

Economic Data

/

+

Total Amount: $45B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
4-week bill auction » 11:38
12/01/22
12/01
11:38
12/01/22
11:38
$ECON

Economic Data

/

+

Total Amount: $45B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
MasTec sees Q1 EBITDA margin profile 'relatively similar' to prior year » 11:33
12/01/22
12/01
11:33
12/01/22
11:33
MTZ

MasTec

$89.41 /

-1.32 (-1.45%)

MasTec CFO George Pita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTZ MasTec
$89.41 /

-1.32 (-1.45%)

MTZ MasTec
$89.41 /

-1.32 (-1.45%)

11/07/22 B. Riley
MasTec price target raised to $112 from $90 at B. Riley
11/07/22 Credit Suisse
MasTec price target raised to $120 from $105 at Credit Suisse
11/07/22 Citi
MasTec price target raised to $103 from $90 at Citi
09/12/22 Citi
Citi opens 'positive Catalyst Watch' on MasTec, Emerson Electric
MTZ MasTec
$89.41 /

-1.32 (-1.45%)

MTZ MasTec
$89.41 /

-1.32 (-1.45%)

Conference/Events
Xilio Therapeutics to host a webcast » 11:29
12/01/22
12/01
11:29
12/01/22
11:29
XLO

Xilio Therapeutics

$2.42 /

+ (+0.00%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLO Xilio Therapeutics
$2.42 /

+ (+0.00%)

XLO Xilio Therapeutics
$2.42 /

+ (+0.00%)

08/10/22 Morgan Stanley
Xilio Therapeutics price target lowered to $20 from $32 at Morgan Stanley
03/14/22 H.C. Wainwright
H.C. Wainwright sees little readthrough for Xilio from Nektar failure
01/10/22 H.C. Wainwright
Xilio Therapeutics initiated with a Buy at H.C. Wainwright
XLO Xilio Therapeutics
$2.42 /

+ (+0.00%)

Hot Stocks
AMC Entertainment trading resumes  11:27
12/01/22
12/01
11:27
12/01/22
11:27
AMC

AMC Entertainment

$7.92 /

+0.68 (+9.39%)

 
ShowHide Related Items >><<
AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

11/25/22 Citi
AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
11/06/22 Citi
AMC Entertainment price target lowered to $1.20 from $3.13 at Citi
10/12/22 B. Riley
AMC Entertainment price target lowered to $7.50 from $11 at B. Riley
08/23/22 Wedbush
Wedbush reiterates Underperform rating on AMC Entertainment, cuts target to $2
AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

AMC AMC Entertainment
$7.92 /

+0.68 (+9.39%)

Options
GameStop call volume above normal and directionally bullish » 11:25
12/01/22
12/01
11:25
12/01/22
11:25
GME

GameStop

$25.70 /

-0.52 (-1.98%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$25.70 /

-0.52 (-1.98%)

GME GameStop
$25.70 /

-0.52 (-1.98%)

10/13/22 Jefferies
GameStop transferred with a Hold at Jefferies
08/16/22 B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
07/22/22 Wedbush
GameStop price target lowered to $7.50 from $30 at Wedbush
05/26/22 Wedbush
Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
GME GameStop
$25.70 /

-0.52 (-1.98%)

GME GameStop
$25.70 /

-0.52 (-1.98%)

GME GameStop
$25.70 /

-0.52 (-1.98%)

GME GameStop
$25.70 /

-0.52 (-1.98%)

Conference/Events
Economic Club of New York holds a luncheon meeting with Chevron CEO » 11:24
12/01/22
12/01
11:24
12/01/22
11:24
CVX

Chevron

$182.43 /

-0.78 (-0.43%)

Chevron CEO Wirth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVX Chevron
$182.43 /

-0.78 (-0.43%)

CVX Chevron
$182.43 /

-0.78 (-0.43%)

11/22/22 Citi
Chevron price target raised to $180 from $155 at Citi
11/11/22 Piper Sandler
Chevron price target raised to $206 from $186 at Piper Sandler
10/31/22 Cowen
Chevron price target raised to $185 from $160 at Cowen
10/24/22 HSBC
Chevron downgraded to Hold from Buy at HSBC
CVX Chevron
$182.43 /

-0.78 (-0.43%)

CVX Chevron
$182.43 /

-0.78 (-0.43%)

CVX Chevron
$182.43 /

-0.78 (-0.43%)

CVX Chevron
$182.43 /

-0.78 (-0.43%)

Hot Stocks
AMC Entertainment trading halted, volatility trading pause  11:22
12/01/22
12/01
11:22
12/01/22
11:22
AMC

AMC Entertainment

$7.87 /

+0.63 (+8.70%)

 
ShowHide Related Items >><<
AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

11/25/22 Citi
AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
11/06/22 Citi
AMC Entertainment price target lowered to $1.20 from $3.13 at Citi
10/12/22 B. Riley
AMC Entertainment price target lowered to $7.50 from $11 at B. Riley
08/23/22 Wedbush
Wedbush reiterates Underperform rating on AMC Entertainment, cuts target to $2
AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

AMC AMC Entertainment
$7.87 /

+0.63 (+8.70%)

Technical Analysis
NASDAQ market internals summary » 11:17
12/01/22
12/01
11:17
12/01/22
11:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 11:16
12/01/22
12/01
11:16
12/01/22
11:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
Ares Capital put volume heavy and directionally bearish » 11:15
12/01/22
12/01
11:15
12/01/22
11:15
ARCC

Ares Capital

$19.35 /

-0.3 (-1.53%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARCC Ares Capital
$19.35 /

-0.3 (-1.53%)

10/27/22 Citi
Ares Capital price target lowered to $21 from $24 at Citi
04/27/22 JPMorgan
Ares Capital upgraded to Overweight from Neutral at JPMorgan
04/27/22 Hovde Group
Ares Capital upgraded to Outperform from Market Perform at Hovde Group
03/07/22 Hovde Group
Ares Capital initiated with a Market Perform at Hovde Group
ARCC Ares Capital
$19.35 /

-0.3 (-1.53%)

  • 08
    Nov
  • 29
    Jul
  • 13
    Jan
ARCC Ares Capital
$19.35 /

-0.3 (-1.53%)

Conference/Events
UBS semiconductor analyst to hold an analyst/industry conference call » 11:15
12/01/22
12/01
11:15
12/01/22
11:15
ADI

Analog Devices

$171.55 /

-0.28 (-0.16%)

Semiconductors Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$171.55 /

-0.28 (-0.16%)

ADI Analog Devices
$171.55 /

-0.28 (-0.16%)

11/23/22 Deutsche Bank
Analog Devices price target raised to $170 from $155 at Deutsche Bank
11/23/22 Evercore ISI
Analog Devices price target raised to $195 from $185 at Evercore ISI
11/23/22 Truist
Analog Devices price target raised to $214 from $209 at Truist
11/23/22 Cowen
Analog Devices price target raised to $190 from $180 at Cowen
ADI Analog Devices
$171.55 /

-0.28 (-0.16%)

ADI Analog Devices
$171.55 /

-0.28 (-0.16%)

ADI Analog Devices
$171.55 /

-0.28 (-0.16%)

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:10
12/01/22
12/01
11:10
12/01/22
11:10
OTIC

Otonomy

/

+

, CNSP

CNS Pharmaceuticals

$3.10 /

+0.07 (+2.31%)

, XFOR

X4 Pharmaceuticals

$1.38 /

-0.16 (-10.39%)

, CRBP

Corbus Pharmaceuticals

/

+

, KALA

Kala Pharmaceuticals

$5.29 /

+ (+0.00%)

These names in the…

ShowHide Related Items >><<
OTIC Otonomy
/

+

CNSP CNS Pharmaceuticals
$3.10 /

+0.07 (+2.31%)

XFOR X4 Pharmaceuticals
$1.38 /

-0.16 (-10.39%)

CRBP Corbus Pharmaceuticals
/

+

KALA Kala Pharmaceuticals
$5.29 /

+ (+0.00%)

OTIC Otonomy
/

+

10/13/22 Piper Sandler
Otonomy downgraded to Neutral at Piper Sandler after OTO-413 fails
10/13/22 Piper Sandler
Otonomy downgraded to Neutral from Overweight at Piper Sandler
08/02/22 H.C. Wainwright
Otonomy downgraded to Neutral from Buy at H.C. Wainwright
08/01/22 Piper Sandler
Otonomy price target lowered to $3 from $6 at Piper Sandler
CNSP CNS Pharmaceuticals
$3.10 /

+0.07 (+2.31%)

08/17/22 Maxim
CNS Pharmaceuticals cut to Hold at Maxim on likely need to raise capital
08/17/22 Maxim
CNS Pharmaceuticals downgraded to Hold from Buy at Maxim
XFOR X4 Pharmaceuticals
$1.38 /

-0.16 (-10.39%)

11/30/22 H.C. Wainwright
X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
08/05/22 H.C. Wainwright
X4 Pharmaceuticals price target lowered to $3.50 from $8.50 at H.C. Wainwright
05/19/22 B. Riley
X4 Pharmaceuticals price target lowered to $7 from $10 at B. Riley
05/13/22 H.C. Wainwright
X4 Pharmaceuticals price target lowered to $8.50 from $11 at H.C. Wainwright
CRBP Corbus Pharmaceuticals
/

+

KALA Kala Pharmaceuticals
$5.29 /

+ (+0.00%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
XFOR X4 Pharmaceuticals
$1.38 /

-0.16 (-10.39%)

KALA Kala Pharmaceuticals
$5.29 /

+ (+0.00%)

OTIC Otonomy
/

+

XFOR X4 Pharmaceuticals
$1.38 /

-0.16 (-10.39%)

CRBP Corbus Pharmaceuticals
/

+

KALA Kala Pharmaceuticals
$5.29 /

+ (+0.00%)

Options
Manchester United call volume above normal and directionally bullish » 11:05
12/01/22
12/01
11:05
12/01/22
11:05
MANU

Manchester United

$22.71 /

+0.605 (+2.74%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MANU Manchester United
$22.71 /

+0.605 (+2.74%)

MANU Manchester United
$22.71 /

+0.605 (+2.74%)

11/23/22 Jefferies
Jefferies expects 'competitive process' for Manchester United
06/02/22 Deutsche Bank
Manchester United undervalued after selloff, says Deutsche Bank
03/21/22 Deutsche Bank
Manchester United upgraded on 'value disconnect' at Deutsche Bank
03/21/22 Deutsche Bank
Manchester United upgraded to Buy from Hold at Deutsche Bank
MANU Manchester United
$22.71 /

+0.605 (+2.74%)

MANU Manchester United
$22.71 /

+0.605 (+2.74%)

MANU Manchester United
$22.71 /

+0.605 (+2.74%)

MANU Manchester United
$22.71 /

+0.605 (+2.74%)

Periodicals
Fisker tells Bloomberg short-seller reports has 'numerous false allegations' » 11:01
12/01/22
12/01
11:01
12/01/22
11:01
FSR

Fisker

$7.16 /

-0.575 (-7.44%)

Fisker additionally told…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSR Fisker
$7.16 /

-0.575 (-7.44%)

FSR Fisker
$7.16 /

-0.575 (-7.44%)

11/29/22 Evercore ISI
Fisker initiated with an Outperform, $15 price target at Evercore ISI
11/29/22 Evercore ISI
Fisker initiated with an Outperform at Evercore ISI
11/03/22 RBC Capital
Fisker cut to Sector Perform at RBC Capital amid growing execution risk
11/03/22 RBC Capital
Fisker downgraded to Sector Perform from Outperform at RBC Capital
FSR Fisker
$7.16 /

-0.575 (-7.44%)

FSR Fisker
$7.16 /

-0.575 (-7.44%)

FSR Fisker
$7.16 /

-0.575 (-7.44%)

FSR Fisker
$7.16 /

-0.575 (-7.44%)

Options
Medical Properties Trust put volume heavy and directionally bearish » 10:55
12/01/22
12/01
10:55
12/01/22
10:55
MPW

Medical Properties Trust

$12.87 /

-0.255 (-1.94%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

11/14/22 BofA
Medical Properties upgraded to Buy at BofA on valuation, upcoming catalysts
11/14/22 BofA
Medical Properties Trust upgraded to Buy from Neutral at BofA
10/21/22 Barclays
Medical Properties Trust price target lowered to $19 from $23 at Barclays
10/12/22 Raymond James
Medical Properties added to Analyst Current Favorites list at Raymond James
MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

MPW Medical Properties Trust
$12.87 /

-0.255 (-1.94%)

General news
Market Action: Wall Street has reversed course » 10:55
12/01/22
12/01
10:55
12/01/22
10:55
$ECON

Economic Data

/

+

Market Action: Wall…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Netgear to hold virtual financial analyst day » 10:55
12/01/22
12/01
10:55
12/01/22
10:55
NTGR

Netgear

$19.88 /

+0.255 (+1.30%)

2022 Virtual Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTGR Netgear
$19.88 /

+0.255 (+1.30%)

NTGR Netgear
$19.88 /

+0.255 (+1.30%)

07/28/22 BWS Financial
Netgear upgraded to Buy from Neutral at BWS Financial
04/28/22 Deutsche Bank
Netgear price target lowered to $22 from $25 at Deutsche Bank
04/19/22 Cowen
Netgear's Q1 miss suggests challenges to persist, says Cowen
04/18/22 BWS Financial
Netgear price target lowered to $27 from $30 at BWS Financial
NTGR Netgear
$19.88 /

+0.255 (+1.30%)

NTGR Netgear
$19.88 /

+0.255 (+1.30%)

General news
Market Action: Wall Street futures are tacking on to yesterday's huge rally » 10:50
12/01/22
12/01
10:50
12/01/22
10:50
$ECON

Economic Data

/

+

Market Action: Wall…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Hoth Therapeutics announces submission of IND application for HT-001 » 10:49
12/01/22
12/01
10:49
12/01/22
10:49
HOTH

Hoth Therapeutics

$4.12 /

-0.04 (-0.96%)

Hoth Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HOTH Hoth Therapeutics
$4.12 /

-0.04 (-0.96%)

  • 12
    Apr
HOTH Hoth Therapeutics
$4.12 /

-0.04 (-0.96%)

On The Fly
Here's What You Missed in Cannabis This Week » 10:47
12/01/22
12/01
10:47
12/01/22
10:47
IGC

India Globalization Capital

/

+

, HITI

High Tide

$1.85 /

-0.02 (-1.07%)

, CGC

Canopy Growth

$3.66 /

+0.03 (+0.83%)

, ETRGF

Entourage Health

/

+

, PLNHF

Planet 13 Holdings

$1.35 /

-0.02 (-1.46%)

, GNLN

Greenlane

/

+

, ACB

Aurora Cannabis

$1.28 /

+0.01 (+0.79%)

, CVSI

CV Sciences

/

+

, CRON

Cronos Group

$3.19 /

+0.085 (+2.74%)

, CTST

CannTrust

/

+

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$13.00 /

+0.3 (+2.36%)

, TLRY

Tilray

$3.93 /

+0.08 (+2.08%)

, TCNNF

Trulieve Cannabis

$12.89 /

-0.07 (-0.54%)

, ZYNE

Zynerba

/

+

, RLMD

Relmada Therapeutics

$4.69 /

+0.05 (+1.08%)

, ATAI

Atai Life Sciences

$3.36 /

-0.15 (-4.27%)

, CMPS

Compass Pathways

$10.17 /

-0.15 (-1.45%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

TCNNF Trulieve Cannabis
$12.89 /

-0.07 (-0.54%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.85 /

-0.02 (-1.07%)

GTBIF Green Thumb Industries
$13.00 /

+0.3 (+2.36%)

GNLN Greenlane
/

+

GDNSF Goodness Growth
/

+

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

CANN General Cannabis
/

+

ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

IGC India Globalization Capital
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
HITI High Tide
$1.85 /

-0.02 (-1.07%)

01/31/22 Desjardins
High Tide price target lowered to C$11.50 from C$13.50 at Desjardins
CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
ETRGF Entourage Health
/

+

06/02/22 Canaccord
Entourage Health downgraded to Hold from Speculative Buy at Canaccord
PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

GNLN Greenlane
/

+

11/16/22 Alliance Global Partners
Greenlane price target lowered to $2 from $6 at Alliance Global Partners
11/01/22 Roth Capital
Greenlane downgraded to Neutral from Buy at Roth Capital
08/17/22 Alliance Global Partners
Greenlane price target raised to $6 from $1.50 at Alliance Global Partners
08/17/22 Canaccord
Greenlane price target lowered to $5 from $20 at Canaccord
ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CVSI CV Sciences
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CTST CannTrust
/

+

CANN General Cannabis
/

+

GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$13.00 /

+0.3 (+2.36%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
TLRY Tilray
$3.93 /

+0.08 (+2.08%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TCNNF Trulieve Cannabis
$12.89 /

-0.07 (-0.54%)

11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
ZYNE Zynerba
/

+

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

HITI High Tide
$1.85 /

-0.02 (-1.07%)

GNLN Greenlane
/

+

ETRGF Entourage Health
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

  • 27
    May
  • 09
    Dec
RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.85 /

-0.02 (-1.07%)

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

Periodicals
Meta attempted to settle E.U. antitrust investigations, Reuters reports » 10:47
12/01/22
12/01
10:47
12/01/22
10:47
META

Meta Platforms

$118.84 /

+0.74 (+0.63%)

Meta reached out to E.U.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
META Meta Platforms
$118.84 /

+0.74 (+0.63%)

META Meta Platforms
$118.84 /

+0.74 (+0.63%)

11/15/22 Morgan Stanley
Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
11/10/22 Canaccord
Meta Platforms price target lowered to $170 from $200 at Canaccord
11/09/22 Itau BBA
Meta Platforms price target raised to $120 from $102 at Itau BBA
11/09/22 Baird
Meta layoffs represent 'significant shift in strategy,' says Baird
META Meta Platforms
$118.84 /

+0.74 (+0.63%)

META Meta Platforms
$118.84 /

+0.74 (+0.63%)

META Meta Platforms
$118.84 /

+0.74 (+0.63%)

META Meta Platforms
$118.84 /

+0.74 (+0.63%)

Options
Moderna call volume above normal and directionally bullish » 10:45
12/01/22
12/01
10:45
12/01/22
10:45
MRNA

Moderna

$179.29 /

+3.55 (+2.02%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$179.29 /

+3.55 (+2.02%)

MRNA Moderna
$179.29 /

+3.55 (+2.02%)

11/28/22 Barclays
Barclays reiterates $210 target on Moderna after PSV deep dive
11/15/22 BofA
Moderna price target raised to $182 from $160 at BofA
11/07/22 Chardan
Moderna price target lowered to $186 from $188 at Chardan
10/25/22 Morgan Stanley
Morgan Stanley expects strong results from Moderna's phase 2 trial in melanoma
MRNA Moderna
$179.29 /

+3.55 (+2.02%)

MRNA Moderna
$179.29 /

+3.55 (+2.02%)

MRNA Moderna
$179.29 /

+3.55 (+2.02%)

MRNA Moderna
$179.29 /

+3.55 (+2.02%)

General news
The U.S. construction spending report undershot estimates » 10:45
12/01/22
12/01
10:45
12/01/22
10:45
$ECON

Economic Data

/

+

The U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.